181 related articles for article (PubMed ID: 11544416)
1. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
[TBL] [Abstract][Full Text] [Related]
2. Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates.
Xu H; Tadaki DK; Elster EA; Burkly LC; Berning JD; Cruzata F; Kampen RL; Montgomery SP; Patterson NB; Harlan DM; Kirk AD
Transplantation; 2002 Oct; 74(7):940-3. PubMed ID: 12394834
[TBL] [Abstract][Full Text] [Related]
3. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
[TBL] [Abstract][Full Text] [Related]
5. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.
Sho M; Sandner SE; Najafian N; Salama AD; Dong V; Yamada A; Kishimoto K; Harada H; Schmitt I; Sayegh MH
Ann Surg; 2002 Nov; 236(5):667-75. PubMed ID: 12409674
[TBL] [Abstract][Full Text] [Related]
6. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation.
Xu H; Elster EA; Blair PJ; Burkly LC; Tadaki DK; Harlan DM; Kirk AD
Am J Transplant; 2003 Nov; 3(11):1350-4. PubMed ID: 14525594
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
[TBL] [Abstract][Full Text] [Related]
10. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.
Kirk AD; Burkly LC; Batty DS; Baumgartner RE; Berning JD; Buchanan K; Fechner JH; Germond RL; Kampen RL; Patterson NB; Swanson SJ; Tadaki DK; TenHoor CN; White L; Knechtle SJ; Harlan DM
Nat Med; 1999 Jun; 5(6):686-93. PubMed ID: 10371508
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.
Oura T; Hotta K; Lei J; Markmann J; Rosales I; Dehnadi A; Kawai K; Ndishabandi D; Smith RN; Cosimi AB; Kawai T
Am J Transplant; 2017 Mar; 17(3):646-656. PubMed ID: 27501203
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
[TBL] [Abstract][Full Text] [Related]
14. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.
Yamada Y; Ochiai T; Boskovic S; Nadazdin O; Oura T; Schoenfeld D; Cappetta K; Smith RN; Colvin RB; Madsen JC; Sachs DH; Benichou G; Cosimi AB; Kawai T
Am J Transplant; 2014 Dec; 14(12):2704-12. PubMed ID: 25394378
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
[TBL] [Abstract][Full Text] [Related]
16. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
17. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
18. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
Kim SC; Wakwe W; Higginbotham LB; Mathews DV; Breeden CP; Stephenson AC; Jenkins J; Strobert E; Price K; Price L; Kuhn R; Wang H; Yamniuk A; Suchard S; Farris AB; Pearson TC; Larsen CP; Ford ML; Suri A; Nadler S; Adams AB
Am J Transplant; 2017 May; 17(5):1182-1192. PubMed ID: 28097811
[TBL] [Abstract][Full Text] [Related]
19. Immune molecular profiling of whole blood drawn from a non-human primate cardiac xenograft model treated with anti-CD154 monoclonal antibodies.
Ock SA; Oh KB; Hwang S; Yun IJ; Ahn C; Chee HK; Kim H; Ullah I; Im GS; Park EW
Xenotransplantation; 2018 Sep; 25(5):e12392. PubMed ID: 29582477
[TBL] [Abstract][Full Text] [Related]
20. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
